Clinical Trial Update: A Study in Subjects With Neurogenic Orthostatic Hypotension [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study in subjects with Neurogenic Orthostatic Hypotension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Orthostatic Hypotension

Snippet

Sponsor: CuraSen Therapeutics, Inc. | Conditions: Neurogenic Orthostatic Hypotension | Phase 2 | Status: RECRUITING